rs2883713

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014905.5(GLS):​c.1131-226G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.467 in 152,040 control chromosomes in the GnomAD database, including 18,647 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 18647 hom., cov: 32)

Consequence

GLS
NM_014905.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.195

Publications

2 publications found
Variant links:
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLSNM_014905.5 linkc.1131-226G>A intron_variant Intron 9 of 17 ENST00000320717.8 NP_055720.3 O94925-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLSENST00000320717.8 linkc.1131-226G>A intron_variant Intron 9 of 17 1 NM_014905.5 ENSP00000317379.3 O94925-1

Frequencies

GnomAD3 genomes
AF:
0.467
AC:
70995
AN:
151920
Hom.:
18633
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.623
Gnomad AMR
AF:
0.429
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.416
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.391
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.471
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.467
AC:
71043
AN:
152040
Hom.:
18647
Cov.:
32
AF XY:
0.469
AC XY:
34895
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.257
AC:
10649
AN:
41464
American (AMR)
AF:
0.429
AC:
6552
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1742
AN:
3466
East Asian (EAS)
AF:
0.167
AC:
864
AN:
5166
South Asian (SAS)
AF:
0.415
AC:
2002
AN:
4820
European-Finnish (FIN)
AF:
0.661
AC:
6985
AN:
10566
Middle Eastern (MID)
AF:
0.390
AC:
113
AN:
290
European-Non Finnish (NFE)
AF:
0.597
AC:
40584
AN:
67974
Other (OTH)
AF:
0.469
AC:
988
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1771
3542
5312
7083
8854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.510
Hom.:
3044
Bravo
AF:
0.439
Asia WGS
AF:
0.336
AC:
1167
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.6
DANN
Benign
0.68
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2883713; hg19: chr2-191788417; API